EPISODE · Dec 4, 2024 · 28 MIN
Episode 169: migraine, plantar fasciitis, beta-blocker duration and prostate cancer
from Primary Care Update · host Mark Ebell
This week Mark, Kate, Gary and Henry talk about the comparative effectiveness of migraine medications, strategies for adults with plantar fascia pain, whether to continue beta-blocker use after acute MI, and the outcomes of 5-alpha reductase inhibitor use prior to prostate cancer diagnosis. Links Migraine: https://www.bmj.com/content/386/bmj-2024-080107 Plantar fasciitis: https://pubmed.ncbi.nlm.nih.gov/38904119/ and https://pubmed.ncbi.nlm.nih.gov/16801514/ Beta-blockers post MI: https://pubmed.ncbi.nlm.nih.gov/39213187/ Prostate cancer: https://pubmed.ncbi.nlm.nih.gov/39190306/
What this episode covers
This week Mark, Kate, Gary and Henry talk about the comparative effectiveness of migraine medications, strategies for adults with plantar fascia pain, whether to continue beta-blocker use after acute MI, and the outcomes of 5-alpha reductase inhibitor use prior to prostate cancer diagnosis. Links Migraine: https://www.bmj.com/content/386/bmj-2024-080107 Plantar fasciitis: https://pubmed.ncbi.nlm.nih.gov/38904119/ and https://pubmed.ncbi.nlm.nih.gov/16801514/ Beta-blockers post MI: https://pubmed.ncbi.nlm.nih.gov/39213187/ Prostate cancer: https://pubmed.ncbi.nlm.nih.gov/39190306/
NOW PLAYING
Episode 169: migraine, plantar fasciitis, beta-blocker duration and prostate cancer
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·31m
Jun 20, 2026 ·24m
Jun 20, 2026 ·42m
Jun 20, 2026 ·26m
Jun 20, 2026 ·22m
Jun 20, 2026 ·37m